Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Biallelic mutations in DNA ligase 1 underlie a spectrum of immune deficiencies
Patrick Maffucci, … , Jean-Laurent Casanova, Charlotte Cunningham-Rundles
Patrick Maffucci, … , Jean-Laurent Casanova, Charlotte Cunningham-Rundles
Published November 5, 2018
Citation Information: J Clin Invest. 2018;128(12):5489-5504. https://doi.org/10.1172/JCI99629.
View: Text | PDF
Research Article Genetics Immunology

Biallelic mutations in DNA ligase 1 underlie a spectrum of immune deficiencies

  • Text
  • PDF
Abstract

We report the molecular, cellular, and clinical features of 5 patients from 3 kindreds with biallelic mutations in the autosomal LIG1 gene encoding DNA ligase 1. The patients exhibited hypogammaglobulinemia, lymphopenia, increased proportions of circulating γδT cells, and erythrocyte macrocytosis. Clinical severity ranged from a mild antibody deficiency to a combined immunodeficiency requiring hematopoietic stem cell transplantation. Using engineered LIG1-deficient cell lines, we demonstrated chemical and radiation defects associated with the mutant alleles, which variably impaired the DNA repair pathway. We further showed that these LIG1 mutant alleles are amorphic or hypomorphic, and exhibited variably decreased enzymatic activities, which lead to premature release of unligated adenylated DNA. The variability of the LIG1 genotypes in the patients was consistent with that of their immunological and clinical phenotypes. These data suggest that different forms of autosomal recessive, partial DNA ligase 1 deficiency underlie an immunodeficiency of variable severity.

Authors

Patrick Maffucci, Jose Chavez, Thomas J. Jurkiw, Patrick J. O’Brien, Jordan K. Abbott, Paul R. Reynolds, Austen Worth, Luigi D. Notarangelo, Kerstin Felgentreff, Patricia Cortes, Bertrand Boisson, Lin Radigan, Aurélie Cobat, Chitra Dinakar, Mohammad Ehlayel, Tawfeg Ben-Omran, Erwin W. Gelfand, Jean-Laurent Casanova, Charlotte Cunningham-Rundles

×

Figure 3

Defective repair of LIG1–/– HEK-293T and mutant cells.

Options: View larger image (or click on image) Download as PowerPoint
Defective repair of LIG1–/– HEK-293T and mutant cells.
(A) LIG1–/– clone...
(A) LIG1–/– clones 37 and 54 were more sensitive to EMS, as compared with HEK-293T cells but similar to each other (2 experiments, 6 replicates; mean ± SD; P = 0.03, P = 0.04). (B) EMS sensitivity of clone 37 cells was rescued by complementation with WT LIG1, but only partially with R641L or R771W (3 experiments, 6 replicates; mean ± SD). (C) Responses of HEK-293T cells to γ radiation: WT HEK-293T cells, clone 37 LIG1–/–, and LIG1–/– + WT LIG1 were irradiated (25 Gy), incubated for 3 hours, and inspected for number of γH2AX foci per nuclei (3 experiments). (D) γH2AX foci/nucleus for HEK-293T cells, LIG1–/–, and LIG1–/– cells complemented with WT LIG1, before and after irradiation with 25 Gy. LIG1–/– cells demonstrated increased foci compared with HEK-293T cells (P = 0.0001), with substantial rescue with WT protein: LIG1–/– versus LIG1 –/– + WT, now P = 0.05 (3 experiments; 50 nuclei/condition counted per experiment; mean ± SD). (E) HEK-293T cells, LIG1–/– cells, and LIG–/– cells transfected with WT LIG1, incubated with media alone or 0.5 mM EMS, and examined by comet assay. Data are mean ± SD and percentage of cellular DNA in the comet tail for 79 to 86 cells/condition; performed 3 times. (F) Comparing DNA damage in 0.5 mM EMS-treated HEK-293T cells to LIG1–/–, T415Mfs*10, R771W, E566K cells, P < 0.0001, to R641L cells, P = 0.69. Adding the P529L variant was similar to adding WT LIG1 (differences, P = 0.9). (G) After 16 hours EMS, LIG1–/–, and mutant cells were washed, replated in fresh media, and tested for the differences in DNA damage at intervals. Mean percent shown for each. At 8 hours, differences emerged: HEK-293T versus LIG1–/–, P = 0.007; LIG1–/– versus T415Mfs*10, P = not significant; LIG1–/– versus R641L, P = 0.02; LIG1–/– versus R771W, P = 0.04 (50–88 colonies/condition).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts